Outcome of thyroid ultrasound screening in FAP patients with a normal baseline exam.


Journal

Familial cancer
ISSN: 1573-7292
Titre abrégé: Fam Cancer
Pays: Netherlands
ID NLM: 100898211

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 14 7 2018
medline: 16 7 2019
entrez: 14 7 2018
Statut: ppublish

Résumé

Familial adenomatous polyposis (FAP) is a hereditary cancer syndrome associated with a substantial lifetime risk for colorectal cancer. The leading extra-colonic causes of cancer in FAP include duodenal and thyroid cancer (TC). Recent guidelines recommend annual thyroid ultrasound (TUS) screening beginning in the teenage years but the evidence to support the interval particularly in FAP patients with a normal baseline ultrasound is lacking. TUS results from FAP patients enrolled in a thyroid screening program from 2006 to 2016 and who had at least 2 TUS were reviewed. TUS findings were classified as normal, low (LR) or high risk (HR) for TC based on nodule characteristics as determined by American Thyroid Association (ATA) guidelines. We assessed the incidence of TC in patient with normal baseline TUS and factors associated with TC. 264 FAP patients were included. Baseline TUS was normal in 167, LR in 74, and HR in 24 patients. Patients were observed for a mean 4.8 years and underwent an average of 3 TUS. Patients with normal baseline TUS did not develop TC during the course of follow up of 5.1 years. TC developed in 6 patients (2.3%) all with baseline nodules; 5 in the LR group and 1 in the HR group. Factors associated with development of TC were presence of baseline nodule(s) and female sex. The development of TC in FAP patients in a TUS screening program with short term follow up is low and no FAP patient with a normal baseline TUS developed TC during observation. Annual TUS in patients with a normal baseline TUS may not be needed. Extending the screening interval to 2 years may be reasonable until nodules are detected.

Identifiants

pubmed: 30003385
doi: 10.1007/s10689-018-0097-z
pii: 10.1007/s10689-018-0097-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-82

Références

World J Surg. 1998 Jul;22(7):738-42; discussion 743
pubmed: 9606291
J Clin Endocrinol Metab. 2013 Feb;98(2):564-70
pubmed: 23275525
J Med Genet. 2018 Jan;55(1):11-14
pubmed: 28490611
J Clin Endocrinol Metab. 2016 Dec;101(12):4611-4617
pubmed: 27623068
J Natl Compr Canc Netw. 2016 Aug;14(8):1010-30
pubmed: 27496117
World J Surg. 1998 Dec;22(12):1231-6
pubmed: 9841749
Clin Gastroenterol Hepatol. 2007 Mar;5(3):367-73
pubmed: 17258512
J Endocrinol Invest. 2010 Oct;33(9):603-6
pubmed: 20935450
Fam Cancer. 2003;2(2):95-9
pubmed: 14574158
N Engl J Med. 1968 May 9;278(19):1056-8
pubmed: 5644968
Gastroenterology. 2005 May;128(6):1696-716
pubmed: 15887160
N Engl J Med. 1993 Feb 25;328(8):553-9
pubmed: 8426623
Ann Surg. 2011 Mar;253(3):515-21
pubmed: 21173694
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
J Clin Endocrinol Metab. 2000 Jan;85(1):286-92
pubmed: 10634400
Thyroid. 2015 Mar;25(3):325-32
pubmed: 25585202
Scand J Gastroenterol. 2000 Dec;35(12):1284-7
pubmed: 11199368
Int J Colorectal Dis. 1997;12(4):240-2
pubmed: 9272455
Ann Surg Oncol. 2008 Sep;15(9):2439-50
pubmed: 18612695
Gut. 1993 Oct;34(10):1394-6
pubmed: 8244108
Br J Surg. 1987 May;74(5):377-80
pubmed: 3036290
Am J Gastroenterol. 2015 Feb;110(2):223-62; quiz 263
pubmed: 25645574
J Mol Diagn. 2013 Jan;15(1):31-43
pubmed: 23159591
Clin Colorectal Cancer. 2012 Dec;11(4):304-8
pubmed: 22425061

Auteurs

Marc Monachese (M)

Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA.

Gautam Mankaney (G)

Department of Gastroenterology and Hepatology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, USA.

Rocio Lopez (R)

Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA.

Margaret O'Malley (M)

Department of Colorectal Surgery, Cleveland Clinic, Cleveland, OH, USA.
Sanford R. Weiss MD Center for Hereditary Colorectal Neoplasia, Cleveland Clinic, Cleveland, OH, USA.

Lisa Laguardia (L)

Department of Colorectal Surgery, Cleveland Clinic, Cleveland, OH, USA.
Sanford R. Weiss MD Center for Hereditary Colorectal Neoplasia, Cleveland Clinic, Cleveland, OH, USA.

Matthew F Kalady (MF)

Department of Colorectal Surgery, Cleveland Clinic, Cleveland, OH, USA.
Sanford R. Weiss MD Center for Hereditary Colorectal Neoplasia, Cleveland Clinic, Cleveland, OH, USA.

James Church (J)

Department of Colorectal Surgery, Cleveland Clinic, Cleveland, OH, USA.
Sanford R. Weiss MD Center for Hereditary Colorectal Neoplasia, Cleveland Clinic, Cleveland, OH, USA.

Joyce Shin (J)

Sanford R. Weiss MD Center for Hereditary Colorectal Neoplasia, Cleveland Clinic, Cleveland, OH, USA.
Department of Endocrine Surgery, Cleveland Clinic, Cleveland, OH, USA.

Carol A Burke (CA)

Department of Gastroenterology and Hepatology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, USA. burkec1@ccf.org.
Department of Colorectal Surgery, Cleveland Clinic, Cleveland, OH, USA. burkec1@ccf.org.
Sanford R. Weiss MD Center for Hereditary Colorectal Neoplasia, Cleveland Clinic, Cleveland, OH, USA. burkec1@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH